(FRHC) Freedom Holding - Ratings and Ratios
Securities, Brokerage, Banking, Insurance, Investments, Trading, Research
FRHC EPS (Earnings per Share)
FRHC Revenue
Description: FRHC Freedom Holding
Freedom Holding Corp (NASDAQ:FRHC) is a diversified financial services company providing a range of services including securities brokerage, investment research, commercial banking, and insurance products through its subsidiaries. Its comprehensive offerings cater to both individual and corporate clients, including retail brokerage services, underwriting, margin lending, investment education, and capital raising solutions.
The companys business model is multifaceted, operating in various geographical regions such as Kazakhstan, Armenia, Cyprus, the United States, and internationally, with its headquarters in New York. It provides services like proprietary trading, investment research, and commercial banking, including digital financial products. The companys platform, Tradernet, is a notable tool for clients, facilitating margin risk evaluation and security transfer requests.
From a performance perspective, key metrics indicate a strong operational capacity. For instance, the Return on Equity (RoE) stands at 6.93%, suggesting a reasonable return for shareholders. The forward Price-to-Earnings ratio is 12.29, which is significantly lower than the current P/E of 113.81, indicating potential future earnings growth. The market capitalization is substantial at $9.75 billion, placing it within a considerable market presence.
To further analyze FRHCs potential, examining its revenue diversification, client acquisition costs, and the growth rate of its various business segments would be crucial. Additionally, assessing the companys competitive positioning within the investment banking and brokerage sub-industry, along with its ability to adapt to regulatory changes and market volatility, is essential. Key Performance Indicators (KPIs) such as client assets under management, trading volume, and the efficiency of its digital platforms could provide deeper insights into its operational health and future prospects.
FRHC Stock Overview
Market Cap in USD | 10,647m |
Sub-Industry | Investment Banking & Brokerage |
IPO / Inception | 2017-10-03 |
FRHC Stock Ratings
Growth Rating | 94.0% |
Fundamental | 72.9% |
Dividend Rating | 0.05% |
Return 12m vs S&P 500 | 48.9% |
Analyst Rating | - |
FRHC Dividends
Currently no dividends paidFRHC Growth Ratios
Growth Correlation 3m | 45.7% |
Growth Correlation 12m | 87.6% |
Growth Correlation 5y | 88.8% |
CAGR 5y | 46.42% |
CAGR/Max DD 3y | 1.32 |
CAGR/Mean DD 3y | 5.06 |
Sharpe Ratio 12m | 2.29 |
Alpha | 0.01 |
Beta | 0.930 |
Volatility | 39.20% |
Current Volume | 116k |
Average Volume 20d | 95.1k |
Stop Loss | 162.1 (-4%) |
Signal | 0.01 |
Piotroski VR‑10 (Strict, 0-10) 3.5
Net Income (80.6m TTM) > 0 and > 6% of Revenue (6% = 123.2m TTM) |
FCFTA 0.12 (>2.0%) and ΔFCFTA 6.01pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 88.54% (prev 106.4%; Δ -17.84pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.13 (>3.0%) and CFO 1.31b > Net Income 80.6m (YES >=105%, WARN >=100%) |
Net Debt (1.21b) to EBITDA (634.6m) ratio: 1.91 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (61.1m) change vs 12m ago 1.33% (target <= -2.0% for YES) |
Gross Margin 48.84% (prev 67.56%; Δ -18.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 22.60% (prev 21.00%; Δ 1.60pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 1.22 (EBITDA TTM 634.6m / Interest Expense TTM 503.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.18
(A) 0.19 = (Total Current Assets 8.48b - Total Current Liabilities 6.67b) / Total Assets 9.69b |
(B) 0.12 = Retained Earnings (Balance) 1.12b / Total Assets 9.69b |
(C) 0.07 = EBIT TTM 615.5m / Avg Total Assets 9.09b |
(D) 0.11 = Book Value of Equity 959.4m / Total Liabilities 8.46b |
Total Rating: 2.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 72.85
1. Piotroski 3.50pt = -1.50 |
2. FCF Yield 12.46% = 5.0 |
3. FCF Margin 58.71% = 7.50 |
4. Debt/Equity 1.42 = 1.57 |
5. Debt/Ebitda 2.75 = -1.38 |
6. ROIC - WACC (= 4.23)% = 5.29 |
7. RoE 6.50% = 0.54 |
8. Rev. Trend 87.40% = 6.56 |
9. EPS Trend -14.49% = -0.72 |
What is the price of FRHC shares?
Over the past week, the price has changed by +1.91%, over one month by -2.33%, over three months by +12.37% and over the past year by +76.43%.
Is Freedom Holding a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FRHC is around 220.75 USD . This means that FRHC is currently undervalued and has a potential upside of +30.75% (Margin of Safety).
Is FRHC a buy, sell or hold?
What are the forecasts/targets for the FRHC price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 76 | -55% |
Analysts Target Price | 76 | -55% |
ValueRay Target Price | 246.8 | 46.2% |
Last update: 2025-09-05 04:43
FRHC Fundamental Data Overview
CCE Cash And Equivalents = 2.71b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 129.8421
P/E Forward = 12.285
P/S = 6.6766
P/B = 8.6199
Beta = 1.136
Revenue TTM = 2.05b USD
EBIT TTM = 615.5m USD
EBITDA TTM = 634.6m USD
Long Term Debt = 670.1m USD (from longTermDebt, last quarter)
Short Term Debt = 1.07b USD (from shortTermDebt, last quarter)
Debt = 1.74b USD (Calculated: Short Term 1.07b + Long Term 670.1m)
Net Debt = 1.21b USD (from netDebt column, last quarter)
Enterprise Value = 9.68b USD (10.65b + Debt 1.74b - CCE 2.71b)
Interest Coverage Ratio = 1.22 (Ebit TTM 615.5m / Interest Expense TTM 503.6m)
FCF Yield = 12.46% (FCF TTM 1.21b / Enterprise Value 9.68b)
FCF Margin = 58.71% (FCF TTM 1.21b / Revenue TTM 2.05b)
Net Margin = 3.93% (Net Income TTM 80.6m / Revenue TTM 2.05b)
Gross Margin = 48.84% ((Revenue TTM 2.05b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Tobins Q-Ratio = 10.09 (Enterprise Value 9.68b / Book Value Of Equity 959.4m)
Interest Expense / Debt = 6.51% (Interest Expense 113.4m / Debt 1.74b)
Taxrate = 25.17% (28.4m / 112.9m)
NOPAT = 460.6m (EBIT 615.5m * (1 - 25.17%))
Current Ratio = 1.27 (Total Current Assets 8.48b / Total Current Liabilities 6.67b)
Debt / Equity = 1.42 (Debt 1.74b / last Quarter total Stockholder Equity 1.23b)
Debt / EBITDA = 2.75 (Net Debt 1.21b / EBITDA 634.6m)
Debt / FCF = 1.45 (Debt 1.74b / FCF TTM 1.21b)
Total Stockholder Equity = 1.24b (last 4 quarters mean)
RoA = 0.83% (Net Income 80.6m, Total Assets 9.69b )
RoE = 6.50% (Net Income TTM 80.6m / Total Stockholder Equity 1.24b)
RoCE = 32.21% (Ebit 615.5m / (Equity 1.24b + L.T.Debt 670.1m))
RoIC = 13.03% (NOPAT 460.6m / Invested Capital 3.53b)
WACC = 8.80% (E(10.65b)/V(12.39b) * Re(9.44%)) + (D(1.74b)/V(12.39b) * Rd(6.51%) * (1-Tc(0.25)))
Shares Correlation 3-Years: 68.70 | Cagr: 0.23%
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 64.41% ; FCFE base≈941.8m ; Y1≈618.3m ; Y5≈282.8m
Fair Price DCF = 73.05 (DCF Value 4.47b / Shares Outstanding 61.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -14.49 | EPS CAGR: -16.22% | SUE: 1.13 | # QB: 1
Revenue Correlation: 87.40 | Revenue CAGR: 49.38% | SUE: 0.0 | # QB: 0
Additional Sources for FRHC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle